Search research articles
Contact Us
Filters
Showing results (1-10 of 67) with videos related to
Page
of 7
Sort By:
Urologic Oncology
|
November 6, 2016
Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
David T Miyamoto, Richard J Lee
Seminars in Radiation Oncology
|
December 8, 2010
Molecular predictors of local tumor control in early-stage breast cancer
David T Miyamoto, Jay R Harris
European Urology
|
September 9, 2020
PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer
David T Miyamoto, Richard J Lee
Plos One
|
June 14, 2013
Concurrent chemoradiation for vaginal cancer
David T Miyamoto, Akila N Viswanathan
Frontiers in Oncology
|
May 27, 2021
Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
Jacob Ukleja, Erika Kusaka, David T Miyamoto
The Urologic Clinics of North America
|
November 24, 2022
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Ikenna Madueke, Richard J Lee, David T Miyamoto
Biomarkers in Medicine
|
December 8, 2016
The promise of circulating tumor cells for precision cancer therapy
William L Hwang, Katie L Hwang, David T Miyamoto
European Urology
|
March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder Cancer
Kent W Mouw, David T Miyamoto, Jason A Efstathiou
Advanced Drug Delivery Reviews
|
January 13, 2018
Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration
William L Hwang, Haley M Pleskow, David T Miyamoto
Nature Reviews. Clinical Oncology
|
May 14, 2014
Circulating tumour cells-monitoring treatment response in prostate cancer
David T Miyamoto, Lecia V Sequist, Richard J Lee
Page
of 7
Search research articles
Search
Showing results (1-10 of 67) with videos related to
Sort By:
Page
of 7
Urologic Oncology
|
November 6, 2016
Cell-free and circulating tumor cell-based biomarkers in men with metastatic prostate cancer: Tools for real-time precision medicine?
David T Miyamoto, Richard J Lee
Seminars in Radiation Oncology
|
December 8, 2010
Molecular predictors of local tumor control in early-stage breast cancer
David T Miyamoto, Jay R Harris
European Urology
|
September 9, 2020
PIK Carefully, AKT Accordingly: Towards Precision Medicine in Prostate Cancer
David T Miyamoto, Richard J Lee
Plos One
|
June 14, 2013
Concurrent chemoradiation for vaginal cancer
David T Miyamoto, Akila N Viswanathan
Frontiers in Oncology
|
May 27, 2021
Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies
Jacob Ukleja, Erika Kusaka, David T Miyamoto
The Urologic Clinics of North America
|
November 24, 2022
Circulating Tumor Cells and Circulating Tumor DNA in Urologic Cancers
Ikenna Madueke, Richard J Lee, David T Miyamoto
Biomarkers in Medicine
|
December 8, 2016
The promise of circulating tumor cells for precision cancer therapy
William L Hwang, Katie L Hwang, David T Miyamoto
European Urology
|
March 27, 2019
Reply from Authors re: Ananya Choudhury, Peter J. Hoskin. Predictive Biomarkers for Muscle-invasive Bladder Cancer: The Search for the Holy Grail Continues. Eur Urol 2019;76:69-70: Towards Biomarker-Informed Management of Muscle-Invasive Bladder Cancer
Kent W Mouw, David T Miyamoto, Jason A Efstathiou
Advanced Drug Delivery Reviews
|
January 13, 2018
Molecular analysis of circulating tumors cells: Biomarkers beyond enumeration
William L Hwang, Haley M Pleskow, David T Miyamoto
Nature Reviews. Clinical Oncology
|
May 14, 2014
Circulating tumour cells-monitoring treatment response in prostate cancer
David T Miyamoto, Lecia V Sequist, Richard J Lee
Page
of 7